Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB01424ApprovedWithdrawnSmall molecule
Aminophenazone is an analgesic drug used to treat acute migraine attacks in combination with ergotamine and caffeine. Aminophenazone is a pyrazolone with analgesic, anti-inflammatory, and antipyretic properties that carries a risk of agranulocytosis.
- Mechanism
- Curator reviewed
Aminophenazone is metabolized very slowly by normal newborn babies. In older infants, a higher amount of exhaled 13-CO2 is observed.
- Primary indication
- Formerly widely used as an antipyretic and analgesic in rheumatism, neuritis, and common colds.Curator reviewed · 1 structured indication
- Formula / weight
- C13H17N3O · 231.2936 g/mol (avg)
- Also known as
- (Dimethylamino)phenazone · 4-Dimethylaminoantipyrine · 4-Dimethylaminophenazone · Aminofenazone · Aminopyrine
- Code names
- NSC-4993
Resolves to
Structure
InChIKey
RMMXTBMQSGEXHJ-UHFFFAOYSA-NSMILESCN(C)C1=C(C)N(C)N(C1=O)C1=CC=CC=C1Targets
Transporters
What you can answer from here — as of September 23, 2026
1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1TransporterSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Aminophenazone, and which of those have an active Phase 3 trial?